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Abstract. Given the complexity and high frequency appearance of urinary disorders in 
cats, the aim of this paper was to establish the toxic dose of nonionic contrast agents in cat 
urography, following the administration of three times the normal dose. The study showed 
slight changes of the biochemical and hematological parameters and the life of the patient was 
never in peril. It was necessary to use non-ionic contrast agents, precisely because they reduce 
the harmfulness of these substances to the body, in comparison with ionic substances which 
are fatal to cats.  
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INTRODUCTION 
 
 X-ray contrast media are chemically inert drugs which are given intravascular in very 
high amounts within a very short time period. Although they are regarded as relatively safe 
drugs, adverse reactions can occur: these are normally divided into immediate and delayed 
reactions. The latter appear hours to days after injection. Immediate reactions have been 
drastically reduced since the introduction of non-ionic monomers and non-ionic dimers. 
However, the delayed reactions still occur in a frequency of 1–3% in X-ray contrast media 
exposed patients. Most of these reactions are mild and manifest themselves as skin eruption, 
but severe reactions can also occur. Further improvement of the safety of these drugs is only 
possible with a better understanding of etiologies behind the observed adverse reactions (1). 
Optiray 160, 240, 300, 320, 350 solution for injection is a nonionic contrast medium 
used in radiology, mainly in cerebral angiography, peripheral, visceral and renal aortography, 
left ventriculography, venography and intravenous urography. Optiray is also indicated in 
computed tomography (CT) of the head and body.  
Intravascular administration of Optiray makes the vessels opaque and facilitates 
radiographic visualization of internal structures until a significant haemodilution substance 
appears. 
 Optiray pharmacokinetic profile, with its hydrophilic properties and a very low level 
of serum and plasma protein binding, indicates that Optiray is distributed in the extracelullar 
space and rapidly eliminated by the kidneys through glomerular filtration. This product 
contains a new entity in Romania, approved through the CEDRAC simplified procedure for 
the authorized products in the European Union (8). 
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METHODS AND MATERIALS 
 
The research was conducted on an adult common breed female cat, weighing 3 kg and 
being clinically healthy. 
 The non-ionic contrast substance used in intravenous Urography in a direct push was 
Optiray, at a dose of 8 ml / kg (normal dose 2.3 ml / kg), containing ioversol. We observed 
the influence of the quantity of substance administered to the body, and we got good 
radiographic images of the urinary system. 
 The biological material was subjected to intravenous Urography in a direct push (as 
administrator of contrast); 
 We used the following methods of investigation: the individual was subjected to 
clinical examination, monitoring the significant semiological constants, as temperature pulse 
and respiration. 
 The next step was to establish a 48 hour diet before the investigation, removing bones 
from its food that could compromise the radiological image of the urinary tract. Instead, it 
received dry food, which was gradually reduced. 24 hours before the investigation the cat 
stopped receiving food, but it still received water ad libitum. This diet was necessary in order 
to increase the elimination of digestive content, of dense and gaseous composition, that might 
affect image quality, leading to false diagnosis. 
 15 minutes before the administration of the contrast substance, the cat has undergone a 
general toilette, by brushing, in order to remove any radio-opaque impurities (such as sand), 
which could affect the Urography image, leading to a negative influence on the interpretation. 
 Given the behavior of the cat near strangers, showing a reserved attitude, being rarely 
friendly or actually aggressive (showing its teeth or claws when the foreign person is trying to 
comfort her), the study required the tranquilization of the subject. The drug substance used 
was Xylazine, administered intramuscularly. Rubbing alcohol was used as a local antiseptic. 
The needles used to manage the substance had a very small diameter (0.2 mm), and the 
syringes used had a volume of 5 and 10 ml. 
 To avoid secondary reactions, before administrating the contrast agents to the patient, 
we used Atropine. 
 After the administration of the contrast agents, samples of blood were collected to 
carry out biochemical and hematological tests. The anticoagulant used was Heparin, which 
was deposited in special containers. The examination of the blood samples was done in the 
laboratory of the Faculty of Veterinary Medicine, the Department of Veterinary Pathology. 
The radiographs were performed in the Roentgen diagnostic laboratory of the Faculty of 
Veterinary Medicine, in Cluj-Napoca, using a SK-7.3.-MEDICAL camera with automatic 
exposure time. 
 Before using the contrast substance, it was warmed up at the body temperature, to 
avoid the appearance of certain side effects that could be due to colder solutions. 
The dose used was according to the weight of the animal (8 ml / kg), and in the end we 
reached the quadrupled dose. 
 We chose to administrate the intravenous contrast substance in the cephalic vein. 
Before puncturing the vessel, the site was aseptically prepared. To highlight the vessel, it was 
necessary to conduct a local vein, using an elastic buttock as a tourniquet. The dye was 
extracted from the phial, preheated to body temperature, only when administered. 
Radiographic exposures were made at certain intervals of time after ceasing the 
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administration of the solution: 3 minutes, 15 minutes, 30 minutes and 1 hour and 15 minutes 
(Images 1, 2, 3, 4).  
 The administration in a direct push of Optiray was performed in the forearm cephalic 
vein, after the area was aseptically prepared. (7)  
 
 
 
RESULTS AND DISCUSSIONS 
 
In the study, it was observed that the patient behaved normally, there were no signs of 
intoxication and the physiological constants remained within physiological limits, except that 
of the body temperature that varied in hypothermia (table 1). 
 
 
 
 
Table 1 
The physiological constants were monitored during determinations 
 
 
 
 
 
 
 
 Before 
tranquilization 
After the 
administration 
of atropine 
and Xylazine 
After the 
administration 
of Optiray 
Blood 
harvesting 15 
minutes after 
the 
administration 
of Optiray 
Blood 
harvesting 30 
minutes after 
the 
administration 
of Optiray 
45  minutes 
after the 
administration 
of  Optiray 
Temperature 36.5 
0
C 37.4 
0
C 36.0 
0
C 35.8 
0
C 34.9 
0
C 35.4 
0
C 
Puls 140/min 184/min 180/min 120/min 135/min 119/min 
Breathing 30/min 44/min 48/min 40/min 35/min 36/min 
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Biochemical tests showed few changes, with 
the exception of a few parameters that were much higher or lower than normal. 
15 minutes after the exposure, the glucose and the γ – amylase were high, and PAL, 
Ca
2+, 
Mg
2+, 
Na
+,
 Fe
3+  
were low (table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Image 1: Radiography, 3 minutes after the 
administration of the contrast substance 
Image 2: Radiography, 15 minutes after 
the administration of the contrast 
substance; 
Image 3: Radiography, 30 minutes after the 
administration of the contrast substance; 
Image 4: Radiography, 1hour and 15 
minutes after the administration of the 
contrast substance. 
 196 
 
 
 
Table 2. 
Constant monitoring of blood serum biochemistry, 15 minutes after the administration of the 
contrast substance 
 
Tests Results Unit Minimum Maximum Observations 
Glucose 230 mg/dl 72 105 High 
Urea 65 mg/dl 30 66  
Creatinine 1.28 mg/dl 0.56 1.808  
ASAT 30 U/L  <35  
ALAT 47 U/L  <60  
GGT 5.1 U/L  <10  
PAL 210 U/L 60 190 High 
Total protein 6.38 g/dl 5 7  
Albumin. 2.86 g/dl 1.5 2.947  
Total Cholesterol 88.31 mg/dl 77.3 251.3  
Triglycerides 46.5 mg/dl 43.75 140  
Uric Acid 0.381 mg/dl - -  
Total Bilirubin. 0.02 mg/dl  < 0.7  
γ - amylase 1100 U/I  <800 High 
Ca
2+
 7.0 mg/dl 8.22 0.92 Low 
Mg
2+
 1.72 mg/dl 2.1 3.2 Low 
Na
+
 120 mmol/l 140 155 Low 
K
+ 
3.4 mmol/l 3.4 5.5  
Fe
3+
 56.7 mg/dl 83 224 Low 
 
 
30 minutes after the exposure, the glucose and γ - amylase remained high, PAL and 
the Total Protein appeared high as well, the Na
+ 
, Fe
3+, 
Ca
2+ 
 appeared low, but reaching 
towards the normal values, and Mg
2+
 returned to the normal value (table 3). 
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Table 3. 
Constant monitoring of blood serum biochemistry, 30 minutes after the administration of the 
contrast substance 
 
Also, the histogram of blood components showed that everything was normal, with the 
exception of the MI, witch was high (table 4). 
 
 
 
 
 
Tests Results Units Minimum Maximum Observations 
Glucose 212.3 mg/dl 72 105 High 
Urea 46.9 mg/dl 30 66  
Creatinine 1.022 mg/dl 0.56 1.808  
ASAT 27.3 U/L  <35  
ALAT 58.4 U/L  <60  
GGT 3.2 U/L  <10  
PAL 280.6 U/L 60 190 High 
Total protein 9.09 g/dl 5 7 High 
Albumin. 3.98 g/dl 1.5 2.947 High 
Total cholesterol 82.9 mg/dl 77.3 251.3  
Triglycerides 43.4 mg/dl 43.75 140  
Uric acid 0.376 mg/dl - -  
Total bilirubin. 0.067 mg/dl  < 0.7  
γ - amylase 1300 U/I  <800 High 
Ca
2+
 8.0 mg/dl 8.22 0.92 Low 
Mg
2+
 2.65 mg/dl 2.1 3.2  
Na
+
 132 mmol/l 140 155 Low 
K
+ 
5.0 mmol/l 3.4 5.5  
Fe
3+
 49.6 mg/dl 83 224 Low 
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Table 4. 
Histogram of blood components, 15 minutes after administrating Optiray 
 
Tests Results Normal limits 
WBC 12.2  10^9/l ( 5.50 – 19.50 ) 
LYM 2.56  10^9/l ( 1.50 – 7.00 ) 
MID 0.98  10^9/l ( < 1.50 ) 
GRA 7.12  10^9/l ( 2.50 – 14.00 ) 
LY% 27.9  % ( 20.0 - 55.0 ) 
MI% +8.7  % ( 1.0 – 3.0 ) 
GR% 63.6  % ( 35.0 – 80.0) 
RBC 8.72  10^12/l ( 5.00 – 10.00)  
HGB 11.7  g/dl ( 8.0 – 15.0 ) 
HTC 33.78  % ( 24.00 – 45.00 ) 
MCV 43  fl ( 39 – 55 ) 
MCH 16.1 pg ( 12. 5 – 17.5 ) 
MCHC 35.9 g/dl ( 30.0 – 36 .0 ) 
RDWc 18.3 %  
PLT 543  10^9/l ( 300 – 800 ) 
PCT 0.53  %  
MPV 12.9 fl ( 12.0 – 17.0 ) 
PDWc 36.6 %  
 
Also, the histogram of blood components showed that the MI was aiming for the 
normal values and it also showed an increase of the MCHC (table5). 
 
Table 5. 
Histogram of blood components, 30 minutes after administrating Optiray 
est Results Normal limits 
WBC 11.00  10^9/l ( 5.50 – 19.50 ) 
LYM 4.21  10^9/l ( 1.50 – 7.00 ) 
MID 0.72 10^9/l ( < 1.50 ) 
GRA 7.26  10^9/l ( 2.50 – 14.00 ) 
LY% 31.0  % ( 20.0 - 55.0 ) 
MI% +5.4  % ( 1.0 – 3.0 ) 
GR% 63.6  % ( 35.0 – 80.0) 
RBC 6.98  10^12/l ( 5.00 – 10.00)  
HGB 11.4  g/dl ( 8.0 – 15.0 ) 
HTC 29.11  % ( 24.00 – 45.00 ) 
MCV 39.3  fl ( 39 – 55 ) 
MCH 13.8 pg ( 12. 5 – 17.5 ) 
MCHC + 38.1  g/dl ( 30.0 – 36 .0 ) 
RDWc 19.7 %  
PLT 411  10^9/l ( 300 – 800 ) 
PCT 0.43  %  
MPV 13.1 fl ( 12.0 – 17.0 ) 
PDWc 32.0 %  
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CONCLUSIONS 
 
 The test showed that there are no significant changes in the biochemical and hematological 
parameters after the administration of four times the normal dose of Optiray.  
 Due to the insignificant changes in the blood, and the well response of the cat after the 
exposure, Optiray is a suitable substance for urographies in cats. However, the study may 
continue on a larger number of cats and the dose can be increased five times to establish 
the toxic dose.  
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